United Therapeutics Reports Q3 2026 Earnings

What Happened

• On August 5, 2026, United Therapeutics Corporation announced its financial results for the quarter ended June 30, 2026 by issuing a press release and filing a Current Report on Form 8‑K. The press release setting forth the quarter’s earnings is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: August 5, 2026.
• Reporting period: Quarter ended June 30, 2026.
• The company issued a press release with the results (Exhibit 99.1).
• The Form 8‑K also includes the cover page formatted in Inline XBRL (Exhibit 104).

Why It Matters

• This 8‑K signals that United Therapeutics has publicly released its latest quarterly results; investors should review the attached press release for the company’s reported revenue, earnings, and any management commentary on performance or guidance. Quarterly earnings releases can affect stock price and investor expectations about future results.